These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29581802)

  • 1. Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.
    Acevedo D; Salvador MP; Girbes J; Estan N
    J Clin Med Res; 2018 May; 10(5):396-404. PubMed ID: 29581802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.
    Garnett E; Pagaduan J; Rajapakshe D; Tam E; Kellermayer R; Devaraj S
    Pract Lab Med; 2020 Nov; 22():e00178. PubMed ID: 33134465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A; D'Incà R; Scapellato ML; De Bastiani R; Caccaro R; Mescoli C; Moz S; Bozzato D; Zambon CF; Lorenzon G; Rugge M; Plebani M; Basso D
    Clin Chem Lab Med; 2018 Oct; 56(11):1926-1935. PubMed ID: 29729144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.
    Hiraoka S; Takashima S; Inokuchi T; Nakarai A; Takahara M; Harada K; Seki Y; Watanabe K; Kato J; Okada H
    Intest Res; 2019 Apr; 17(2):202-209. PubMed ID: 30541228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease.
    El-Matary W; Abej E; Deora V; Singh H; Bernstein CN
    Front Pediatr; 2017; 5():7. PubMed ID: 28180127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay.
    Lin L; Wyness SP; Jensen R; Bird J; Norgyal T; Jensen G; Johnson LM
    Am J Clin Pathol; 2022 Feb; 157(2):252-256. PubMed ID: 34390332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis.
    Hejl J; Theede K; Møllgren B; Madsen KV; Heidari A; Á Steig A; Fenger M
    Pract Lab Med; 2018 Mar; 10():10-14. PubMed ID: 29234707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin in patients with liver cirrhosis.
    Jothimani D; Paramasivam R; Manoharan M; Ramachandran H; Muthusamy S; Simon E; Ravichandran J; Rela M
    Indian J Gastroenterol; 2023 Dec; 42(6):818-823. PubMed ID: 37823985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
    Goutorbe F; Goutte M; Minet-Quinard R; Boucher AL; Pereira B; Bommelaer G; Buisson A
    J Crohns Colitis; 2015 Dec; 9(12):1113-9. PubMed ID: 26351383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.
    Mandic-Havelka A; Nilsen T; Sunde K; Norell M; Hansson LO; Larsson A
    Clin Lab; 2017 May; 63(5):907-913. PubMed ID: 28627817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease.
    Abedin N; Seemann T; Kleinfeld S; Ruehrup J; Röseler S; Trautwein C; Streetz K; Sellge G
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31756948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of the fCAL turbo immunoturbidimetric assay for measurement of the fecal calprotectin concentration in dogs and cats.
    Enderle LL; Köller G; Heilmann RM
    J Vet Diagn Invest; 2022 Sep; 34(5):813-824. PubMed ID: 35879875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
    Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of the Bühlmann fCAL turbo faecal calprotectin assay on the Binding Site Optilite benchtop analyser.
    Handley SA; Dote NP; Wanandy T; Prentice L
    Pract Lab Med; 2023 Aug; 36():e00318. PubMed ID: 37649548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inokuchi T; Kato J; Hiraoka S; Takashima S; Nakarai A; Takei D; Sugihara Y; Takahara M; Kawano S; Harada K; Okada H
    Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease.
    Abej E; El-Matary W; Singh H; Bernstein CN
    Can J Gastroenterol Hepatol; 2016; 2016():2483261. PubMed ID: 27774443
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
    Buisson A; Mak WY; Andersen MJ; Lei D; Kahn SA; Pekow J; Cohen RD; Zmeter N; Pereira B; Rubin DT
    J Crohns Colitis; 2019 Aug; 13(8):1012-1024. PubMed ID: 30726887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.
    Matzkies FG; Targan SR; Berel D; Landers CJ; Reveille JD; McGovern DP; Weisman MH
    Arthritis Res Ther; 2012 Nov; 14(6):R261. PubMed ID: 23194008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.